<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04172324</url>
  </required_header>
  <id_info>
    <org_study_id>18/44/509</org_study_id>
    <nct_id>NCT04172324</nct_id>
  </id_info>
  <brief_title>Walking in the HIBBOT: is Gait Improved?</brief_title>
  <official_title>The Effect of a Novel Gait Trainer, the Hibbot, on the Development of Crouch Gait in Children With Cerebral Palsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universiteit Antwerpen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universiteit Antwerpen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to assess the impact of the innovative walking aid HIBBOT on the
      functions, activity and participation of young children with Cerebral Palsy, in comparison
      with conventional walking aids.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Lower limb kinematics during walking in degrees</measure>
    <time_frame>baseline (at intake, T0) and after the intervention period (3 months, T1)</time_frame>
    <description>The gait pattern is assessed by instrumented 3D gait analysis. Joint rotation angles of the major joints of the lower limbs will be described during walking.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Muscle activation patterns during gait in microvolts</measure>
    <time_frame>baseline (at intake, T0) and after the intervention period (3 months, T1)</time_frame>
    <description>Surface electromyography signals will be recorded during gait</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lower limb kinematics during walking in degrees</measure>
    <time_frame>at follow up (12 months after intake, T2)</time_frame>
    <description>The gait pattern is assessed by instrumented 3D gait analysis. Joint rotation angles of the major joints of the lower limbs will be described during walking.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle activation patterns during gait in microvolts</measure>
    <time_frame>at follow up (12 months after intake, T2)</time_frame>
    <description>Surface electromyography signals will be recorded during gait</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>Hibbot</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HIBBOT</intervention_name>
    <description>Hibbot is an assistive mechanical device, lightweight and portable. The mechanism of the Hibbot manages to control all degrees of freedom (3x rotation and 3x translation) at the level of the pelvis and lower trunk. The goal is to maximize a child's own muscle activity and postural control while giving as minimal support as needed.</description>
    <arm_group_label>Hibbot</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Care</intervention_name>
    <description>Standard care involves the standard physiotherapy the child would get during clinical care.</description>
    <arm_group_label>Hibbot</arm_group_label>
    <arm_group_label>Standard Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At risk of or diagnosed with cerebral palsy, based on MRI (uCP 86 - 89 % sensitivity)
             or HINE (uCP 98% ) or standard motor assessment

          -  age 18 months - 6 years

          -  GMFCS level II - IV =with potential (=able to stand and walk when supported by a
             therapist at the level of the pelvis and lower trunk)

          -  Sufficient cooperation to complete the tests.

        Exclusion Criteria:

          -  Hip dysplasia

          -  Fixed contractures in the lower limb

          -  Botox infiltration &lt; 6 months prior to inclusion

          -  Surgery &lt; 12 months prior to inclusion

          -  Insufficient understanding of the interventon and tests (based on mental level
             assessment)

          -  Refractary epilepsia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Antwerp</name>
      <address>
        <city>Antwerp</city>
        <zip>2160</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Hallemans, PhD</last_name>
      <phone>+32 3 265 29 12</phone>
      <email>ann.hallemans@uantwerpen.be</email>
    </contact>
    <contact_backup>
      <last_name>PhD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 18, 2019</study_first_submitted>
  <study_first_submitted_qc>November 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2019</study_first_posted>
  <last_update_submitted>November 20, 2019</last_update_submitted>
  <last_update_submitted_qc>November 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universiteit Antwerpen</investigator_affiliation>
    <investigator_full_name>Ann Hallemans</investigator_full_name>
    <investigator_title>Assistent Professor, Research Group MOVANT, Department of Rehabilitation Sciences and Physiotherapy - Head of the Multidisciplinary Motor Center Antwerp</investigator_title>
  </responsible_party>
  <keyword>gait</keyword>
  <keyword>biomechanics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</ipd_description>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>At finalisation of the study and for a period of 5 years</ipd_time_frame>
    <ipd_access_criteria>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

